Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bonelli

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|August 3, 2021
Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Michael Bonelli, Daniel Aletaha
Current Opinion in Rheumatology|February 6, 2018
How does abatacept really work in rheumatoid arthritis?Michael Bonelli, Clemens Scheinecker
Annals of the Rheumatic Diseases|July 17, 2021
Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff <i>et al</i>Michael Bonelli, Daniel Aletaha
Current Pharmaceutical Design|May 13, 2022
Neuropsychiatric Systemic Lupus Erythematosus: A Remaining ChallengeDaniel Mrak, Michael Bonelli, Helga Radner
Seminars in Immunopathology|April 7, 2019
Treg cells in autoimmunity: from identification to Treg-based therapiesLisa Göschl, Clemens Scheinecker, Michael Bonelli
Journal of Autoimmunity|December 22, 2019
Treg cells in health and autoimmune diseases: New insights from single cell analysisClemens Scheinecker, Lisa Göschl, Michael Bonelli
Bioinformatics (Oxford, England)|March 2, 2026
SummArIzeR: Simplifying cross-database enrichment result clustering and annotation via large language modelsMarie Brinkmann, Michael Bonelli, Anela Tosevska
Journal of Autoimmunity|July 20, 2010
Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cellsClemens Scheinecker, Michael Bonelli, Josef S Smolen
Nature Reviews. Rheumatology|December 4, 2015
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesDaniella M Schwartz, Michael Bonelli, Massimo Gadina, et al.
Annals of the Rheumatic Diseases|May 3, 2024
Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseasesMarkus H Hoffmann, Henriette Kirchner, Gerhard Krönke, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|August 3, 2021
Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Michael Bonelli, Daniel Aletaha
Current Opinion in Rheumatology|February 6, 2018
How does abatacept really work in rheumatoid arthritis?Michael Bonelli, Clemens Scheinecker
Annals of the Rheumatic Diseases|July 17, 2021
Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff <i>et al</i>Michael Bonelli, Daniel Aletaha
Current Pharmaceutical Design|May 13, 2022
Neuropsychiatric Systemic Lupus Erythematosus: A Remaining ChallengeDaniel Mrak, Michael Bonelli, Helga Radner
Seminars in Immunopathology|April 7, 2019
Treg cells in autoimmunity: from identification to Treg-based therapiesLisa Göschl, Clemens Scheinecker, Michael Bonelli
Journal of Autoimmunity|December 22, 2019
Treg cells in health and autoimmune diseases: New insights from single cell analysisClemens Scheinecker, Lisa Göschl, Michael Bonelli
Bioinformatics (Oxford, England)|March 2, 2026
SummArIzeR: Simplifying cross-database enrichment result clustering and annotation via large language modelsMarie Brinkmann, Michael Bonelli, Anela Tosevska
Journal of Autoimmunity|July 20, 2010
Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cellsClemens Scheinecker, Michael Bonelli, Josef S Smolen
Nature Reviews. Rheumatology|December 4, 2015
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesDaniella M Schwartz, Michael Bonelli, Massimo Gadina, et al.
Annals of the Rheumatic Diseases|May 3, 2024
Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseasesMarkus H Hoffmann, Henriette Kirchner, Gerhard Krönke, et al.
Pageof 8